GlycoErase™ B4GALT7 Knockout Human Ovarian Cancer Cell A2780 (CAT#: GLJF-0525-JF1151)

Description	B4GALT7 knockout A2780 cells, deficient in beta-1,4-galactosyltransferase 7, a beta4GalT family member with diverse glycosylation functions, allow investigation of glycoconjugate biosynthesis disruption, potentially affecting diverse beta-1,4-galactosyltransferase dependent glycosylation pathways and broader glycosylatioN-related processes due to beta4GalT family disruption.
Product Type	KO Cell Lines
Species	Human
Cell Morphology	Epithelial-like, adherent
Passage Ratio	1:3~1:6
Cell Line	A2780
Primary Disease	Ovarian Epithelial Tumor
Lineage	Ovary/Fallopian Tube

Cell Viability	>90%
Sterility Test	The sterility test indicated an absence of microbial growth.
Identity Test	STR identification
Mycoplasma Test	Negative
Virus Test	Negative for HIV, HBV and HCV.
Genetic Stability Testing	We conduct cell genetic stability studies in full compliance with ICH guidelines. Our expertise enables us to design and execute a comprehensive testing program tailored to your specific needs and regulatory requirements.
Validation	PCR, Sanger Sequencing
Culture Medium	FBS & Glutamine & RPMI
Application	Functional assay
Size	1 M cells/vial*2
Product Format	Frozen
Shipping	Dry ice
Availability Status	Made to order
Handling Notes	Upon receipt, this product must be immediately transferred from dry ice to liquid nitrogen (-150°C to -190°C) and stored in a liquid nitrogen tank. Cell viability is critically dependent on proper handling. We cannot guarantee viability if these instructions are not strictly adhered to.
Product Disclaimer	This product is provided for research only, not suitable for human or animal use. Due to the inherent limitations of infectious agent testing, investigators must exercise extreme caution when handling cells provided by Creative Biolabs, treating all cells as potentially biohazardous.

Target	B4GALT7
Full Name	Beta-1,4-galactosyltransferase 7
Alternative Name	beta4Gal-T7, XGALT-1
Location	5q35.3
Gene ID	11285
Summary	Beta-1,4-galactosyltransferase with exclusive specificity for UDP-galactose; involved in the biosynthesis of various glycoconjugates and saccharide structures.